APA Alıntı

Basu, B., Krebs, M. G., Sundar, R., Wilson, R. H., Spicer, J., Jones, R., . . . Banerji, U. (2018). Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer. Ann Oncol.

Chicago Stili Alıntı

Basu, B., et al. "Vistusertib (dual M-TORC1/2 Inhibitor) in Combination With Paclitaxel in Patients With High-grade Serous Ovarian and Squamous Non-small-cell Lung Cancer." Ann Oncol 2018.

MLA Alıntı

Basu, B., et al. "Vistusertib (dual M-TORC1/2 Inhibitor) in Combination With Paclitaxel in Patients With High-grade Serous Ovarian and Squamous Non-small-cell Lung Cancer." Ann Oncol 2018.